FOLH1 and prostate cancer: 27080322 27080322 Rowe SP, Macura KJ, Mena E et al (2016) PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.